WO2009130465A3 - Marqueurs - Google Patents

Marqueurs Download PDF

Info

Publication number
WO2009130465A3
WO2009130465A3 PCT/GB2009/001036 GB2009001036W WO2009130465A3 WO 2009130465 A3 WO2009130465 A3 WO 2009130465A3 GB 2009001036 W GB2009001036 W GB 2009001036W WO 2009130465 A3 WO2009130465 A3 WO 2009130465A3
Authority
WO
WIPO (PCT)
Prior art keywords
adhd
alcoholism
genetic markers
psychic disorders
disorders
Prior art date
Application number
PCT/GB2009/001036
Other languages
English (en)
Other versions
WO2009130465A2 (fr
Inventor
Hugh Malcolm Douglas Gurling
Andrew Mcquillan
Susan Clare Stanford
Stephen Hunt
Original Assignee
Ucl Business Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucl Business Plc filed Critical Ucl Business Plc
Publication of WO2009130465A2 publication Critical patent/WO2009130465A2/fr
Publication of WO2009130465A3 publication Critical patent/WO2009130465A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des marqueurs permettant d’identifier une susceptibilité accrue à l’un ou à plusieurs des problèmes suivants : troubles déficitaires de l’attention avec hyperactivité (ADHD), alcoolisme, troubles affectifs bipolaires et unipolaires, trouble de la conduite, autodestruction et suicidabilité chez des individus.
PCT/GB2009/001036 2008-04-23 2009-04-23 Marqueurs WO2009130465A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0807421A GB0807421D0 (en) 2008-04-23 2008-04-23 Markers
GB0807421.3 2008-04-23

Publications (2)

Publication Number Publication Date
WO2009130465A2 WO2009130465A2 (fr) 2009-10-29
WO2009130465A3 true WO2009130465A3 (fr) 2010-01-28

Family

ID=39494122

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2009/001036 WO2009130465A2 (fr) 2008-04-23 2009-04-23 Marqueurs

Country Status (2)

Country Link
GB (1) GB0807421D0 (fr)
WO (1) WO2009130465A2 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001071029A1 (fr) * 2000-03-21 2001-09-27 Hormos Medical Corporation Diagnostic du risque de developper un alcoolisme chez une personne
WO2002090541A1 (fr) * 2001-05-03 2002-11-14 Murdoch Childrens Research Institute Determination d'une predisposition genetique a des troubles comportementaux
WO2007052166A2 (fr) * 2005-10-14 2007-05-10 Institut Pasteur Variations genetiques associees a des troubles psychiatriques

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001071029A1 (fr) * 2000-03-21 2001-09-27 Hormos Medical Corporation Diagnostic du risque de developper un alcoolisme chez une personne
WO2002090541A1 (fr) * 2001-05-03 2002-11-14 Murdoch Childrens Research Institute Determination d'une predisposition genetique a des troubles comportementaux
WO2007052166A2 (fr) * 2005-10-14 2007-05-10 Institut Pasteur Variations genetiques associees a des troubles psychiatriques

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE SNP [online] 8 October 2004 (2004-10-08), XP002544231, retrieved from NCBI Database accession no. rs3771829 *

Also Published As

Publication number Publication date
GB0807421D0 (en) 2008-05-28
WO2009130465A2 (fr) 2009-10-29

Similar Documents

Publication Publication Date Title
WO2009117122A3 (fr) Analyse génétique
GT201200189A (es) Antagonistas de pcsk9
PH12015502362A1 (en) Certain chemical entities, compositions and methods
WO2009114475A3 (fr) Compositions comprenant de la pcsk9 humaine et un siarn d’apolipoprotéine b, et procédés d’utilisation de celles-ci
WO2012088290A3 (fr) Protéines de liaison à trois domaines variables et leurs utilisations
WO2009108217A3 (fr) Compositions comprenant un arnsi de k-ras et procédés d’utilisation
WO2011141823A3 (fr) Méthodes de traitement et/ou de prévention de troubles de prolifération cellulaire à l'aide d'antagonistes de il-17
EA201200793A1 (ru) Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин
WO2008067121A3 (fr) Méthodes de traitement des troubles cognitifs et de la démence
WO2011038155A3 (fr) Analyse génétique
WO2010009478A3 (fr) Compositions et procédés pour traiter des troubles associés à des animaux en surpoids
WO2009002440A3 (fr) Compositions comprenant un arnsi de egfr humain et leurs procédés d'utilisation
WO2009095489A3 (fr) Séquences d'acides aminés améliorées dirigées contre il-6r et polypeptides les comprenant pour le traitement de maladies et troubles associés à une signalisation facilitée par il-6
IN2012DN02471A (fr)
WO2009150255A3 (fr) Marqueurs destinés à prédire la réponse et la survie de patients traités anti-egfr
BR112014027303A2 (pt) identificação de variantes de isopreno sintase com propriedades optimizadas para a produção de isopreno
WO2009039189A3 (fr) Compositions comprenant des arnsi de stat3 et leurs procédés d'utilisation
EP2209759A4 (fr) Fabrication de 1,1,1,2,3,3-hexafluoropropane and 1,1,1,2-tétrafluoropropane par l'hydrogénation catalytique
MX2012004548A (es) Nuevas composiciones para prevenir y/o tratar transtornos degenerativos del sistema nervioso central.
WO2008066769A3 (fr) Diagnostic génétique de dépression
WO2009140557A3 (fr) Formulations de toltérodine à libération modifiée
WO2011014520A3 (fr) Composés et compositions pouvant servir de modulateurs de l'activité du gpr119
WO2009143371A3 (fr) Compositions comportant un arnsi des voies mtor et leurs procédés d’utilisations
MX2009009693A (es) Metodos para activar irs-1 y akt.
WO2011140334A3 (fr) Composés, méthodes de fabrication ou d'identification de composés et leurs utilisations

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09734084

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09734084

Country of ref document: EP

Kind code of ref document: A2